Parameters associated with adverse perinatal outcome in hypertensive pregnancies
- PMID: 8895034
Parameters associated with adverse perinatal outcome in hypertensive pregnancies
Abstract
Background: Hypertensive disorders are a major contributor to perinatal morbidity and mortality. As all hypertensive pregnancies do not have a bad outcome, we sought to identify clinical and laboratory parameters associated with adverse perinatal outcome in hypertensive pregnancies.
Methods: We analyzed the clinical course of 271 hypertensive patients delivered at a tertiary center. Adverse perinatal outcome included: (1) perinatal death; and (2) perinatal morbidity due to hypertension-related prematurity and uteroplacental vasculopathy. In our analysis, we sought to compare good and adverse perinatal outcome groups of hypertensive pregnancies. Two sample t-tests were used for continuous variables and chi 2-tests were performed for categoric variables. Blood pressures (BP) were analyzed by multivariate analysis for four time periods (P, I through IV) defined by gestational age in weeks: I, 10-19; II, 20-24; III, 25-29; and IV, 30-36.
Results: There were 96 cases of adverse perinatal outcome due to hypertension (mortality, n = 6; morbidity, n = 90) in this series. Two clinical factors had a significant association with adverse perinatal outcome: (1) the need for prenatal treatment with antihypertensives (P < 0.0001); and (2) early onset of hypertension during the pregnancy (P < 0.008). The adverse outcome group had higher systolic (S) BP as early as 10-19 weeks (P < 0.01). This group had higher systolic and diastolic (D) BP as early as 20-24 weeks' gestation (P < 0.004-0.0001). Serum uric acid of > or = 6 mg/dl had a relative risk of 4.2 for adverse perinatal outcome (95% CI, 2.0-8.9; P < 0.0001).
Conclusions: Our study suggests that the increased severity and longer duration of hypertension may be the primary pathophysiologic mediator of adverse perinatal effects in these pregnancies. Elevated serum uric acid may be a clinically useful predictor of perinatal mortality and, more importantly, of perinatal morbidity in hypertensive pregnancies.
Similar articles
-
Perinatal outcome in growth-restricted fetuses: do hypertensive and normotensive pregnancies differ?Obstet Gynecol. 1996 Aug;88(2):194-9. doi: 10.1016/0029-7844(96)02169-2. Obstet Gynecol. 1996. PMID: 8692500
-
Maternal and perinatal outcome in pregnancies complicated with hypertensive disorder of pregnancy: a seven year experience of a tertiary care center.Arch Gynecol Obstet. 2005 Nov;273(1):43-9. doi: 10.1007/s00404-005-0741-3. Epub 2005 Apr 15. Arch Gynecol Obstet. 2005. PMID: 15834580
-
Association of uric acid with progression to preeclampsia and development of adverse conditions in gestational hypertensive pregnancies.Am J Hypertens. 2012 Jun;25(6):711-7. doi: 10.1038/ajh.2012.18. Epub 2012 Mar 1. Am J Hypertens. 2012. PMID: 22378034
-
Chronic hypertension in pregnancy.Minerva Ginecol. 2003 Feb;55(1):1-13. Minerva Ginecol. 2003. PMID: 12598838 Review.
-
Hypertension in pregnancy.J Hypertens Suppl. 1985 Dec;3(3):S395-403. J Hypertens Suppl. 1985. PMID: 2856749 Review.
Cited by
-
Uric acid: is it time to give up routine testing in management of pre-eclampsia?Obstet Med. 2012 Sep;5(3):119-23. doi: 10.1258/om.2011.110075. Epub 2012 Mar 29. Obstet Med. 2012. PMID: 27582868 Free PMC article.
-
High Uric Acid Levels During Pregnancy Linked to Increased Risk for Future Atherosclerotic-Related Hospitalization.J Clin Hypertens (Greenwich). 2015 Jun;17(6):481-5. doi: 10.1111/jch.12535. Epub 2015 Mar 23. J Clin Hypertens (Greenwich). 2015. PMID: 25808139 Free PMC article.
-
Biochemical tests of placental function versus ultrasound assessment of fetal size for stillbirth and small-for-gestational-age infants.Cochrane Database Syst Rev. 2019 May 14;5(5):CD012245. doi: 10.1002/14651858.CD012245.pub2. Cochrane Database Syst Rev. 2019. PMID: 31087568 Free PMC article.
-
Pathophysiology and medical management of systemic hypertension in preeclampsia.Curr Hypertens Rep. 2006 Dec;8(6):502-11. doi: 10.1007/s11906-006-0030-y. Curr Hypertens Rep. 2006. PMID: 17087860 Review.
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials